NAGLAZYME
BioMarin Pharmaceutical Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78629370 |
| Registration Number | 3132316 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Gregory J. Chinlund |
| Attorney Docket Number | 30610/61761 |
| Law Office Assigned | M60 |
| Employee Name | PHAM, LANA H |
Timeline
| 2005-05-13 | Application Filed |
| 2005-06-08 | Date of First Use |
| 2006-02-21 | Published for Opposition |
| 2006-08-22 | Trademark Registered |
| 2015-09-28 | Location: GENERIC WEB UPDATE |
| 2015-09-28 | Status: Live/Registered |
| 2016-08-22 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  BioMarin Pharmaceutical Inc. |
| Address | 105 Digital Drive Novato DE 94949 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations, namely pharmaceuticals for use in treatment of lysosomal storage disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2005-05-20 | 1 NWAP I:Incoming Correspondence |
| TEAS AMENDMENT OF USE RECEIVED | 2005-11-02 | 2 EAAU I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-12-10 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2005-12-14 | 4 CNEA R:Renewal |
| EXAMINER'S AMENDMENT ENTERED | 2005-12-14 | 5 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-12-14 | 6 CNSA P: |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2005-12-14 | 7 ZZZX Z:Deletion |
| USE AMENDMENT FILED | 2005-12-14 | 8 IUAF S: |
| AMENDMENT TO USE PROCESSING COMPLETE | 2005-12-14 | 9 AUPC I:Incoming Correspondence |
| USE AMENDMENT ACCEPTED | 2005-12-14 | 10 IUAA P: |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-12-14 | 11 CNSA O:Outgoing Correspondence |
| CORRESPONDENCE MAILED | 2005-12-15 | 12 CRML O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-12-16 | 13 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2006-01-09 | 14 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-02-01 | 15 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-02-21 | 16 PUBO A:Allowance for Publication |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2006-03-17 | 17 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2006-07-07 | 18 ETOP T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2006-08-22 | 19 R.PR A:Allowance for Publication |
| TEAS SECTION 8 & 15 RECEIVED | 2012-03-06 | 20 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-04-04 | 21 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2012-04-05 | 22 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2012-04-05 | 23 NA85 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2015-08-22 | 24 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2015-08-28 | 25 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2015-09-28 | 26 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2015-09-28 | 27 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2015-09-28 | 28 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2015-09-28 | 29 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 NAGLAZYME 78819328 3193328 Live/Registered |
BioMarin Pharmaceutical Inc. 2006-02-21 |
 NAGLAZYME 78629370 3132316 Live/Registered |
BioMarin Pharmaceutical Inc. 2005-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 